0.016260 0.000000 0.006669 0.000000 0.022075 0.000000 0.000000 0.000000 0.013910 0.00000 0.00000 0.00000 Robinson, R.C. Heath, J.K. Hawkins, N. Samal, B. Jones, E.Y. Betzel, C. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 4 90.0 112.3 90.0 61.5 45.3 77.7 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking to be published 0353 Species Variation in Receptor Binding Site Revealed by the Medium Resolution X-ray Structure of Human Leukemia Inhibitory Factor NE FEBS Lett. FEBLAL 0165 0014-5793 336 236 238 10.1016/0014-5793(93)80810-H Crystallization and Preliminary X-ray Analysis of Leukemia Inhibitory Factor 1993 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 293 1 AREA DETECTOR 1993-01-15 MARRESEARCH SINGLE WAVELENGTH M x-ray 1 0.9 1.0 DW32 LURE 0.9 SYNCHROTRON LURE BEAMLINE DW32 17515.262 LEUKEMIA INHIBITORY FACTOR 1 man polymer LIF no no LMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLEKLCGPNVTDFPPFHANGTEKAKLVELYRIVVYLGTSLGNITRDQ KILNPSALSLHSKLNATADILRGLLSNVLCRLCSKYHVGHVDVTYGPDTSGKDVFQKKKLGCQLLGKYKQVISVLAQAF LMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLEKLCGPNVTDFPPFHANGTEKAKLVELYRIVVYLGTSLGNITRDQ KILNPSALSLHSKLNATADILRGLLSNVLCRLCSKYHVGHVDVTYGPDTSGKDVFQKKKLGCQLLGKYKQVISVLAQAF A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo Escherichia sample 9606 Homo sapiens 562 Escherichia coli 1 2.86 56.95 VAPOR DIFFUSION, SITTING DROP 6.0 200 mM sodium acetate, 100 mM cacodylate buffer, 30% w/v PEG 8000, pH 6.0, VAPOR DIFFUSION, SITTING DROP, temperature 289K 289 repository Initial release Version format compliance Version format compliance 1 0 2001-03-21 1 1 2008-04-27 1 2 2011-07-13 RCSB Y RCSB 2000-03-17 REL LEU 23 n 1 LEU 23 A MET 24 n 2 MET 24 A ASN 25 n 3 ASN 25 A GLN 26 n 4 GLN 26 A ILE 27 n 5 ILE 27 A ARG 28 n 6 ARG 28 A SER 29 n 7 SER 29 A GLN 30 n 8 GLN 30 A LEU 31 n 9 LEU 31 A ALA 32 n 10 ALA 32 A GLN 33 n 11 GLN 33 A LEU 34 n 12 LEU 34 A ASN 35 n 13 ASN 35 A GLY 36 n 14 GLY 36 A SER 37 n 15 SER 37 A ALA 38 n 16 ALA 38 A ASN 39 n 17 ASN 39 A ALA 40 n 18 ALA 40 A LEU 41 n 19 LEU 41 A PHE 42 n 20 PHE 42 A ILE 43 n 21 ILE 43 A LEU 44 n 22 LEU 44 A TYR 45 n 23 TYR 45 A TYR 46 n 24 TYR 46 A THR 47 n 25 THR 47 A ALA 48 n 26 ALA 48 A GLN 49 n 27 GLN 49 A GLY 50 n 28 GLY 50 A GLU 51 n 29 GLU 51 A PRO 52 n 30 PRO 52 A PHE 53 n 31 PHE 53 A PRO 54 n 32 PRO 54 A ASN 55 n 33 ASN 55 A ASN 56 n 34 ASN 56 A LEU 57 n 35 LEU 57 A GLU 58 n 36 GLU 58 A LYS 59 n 37 LYS 59 A LEU 60 n 38 LEU 60 A CYS 61 n 39 CYS 61 A GLY 62 n 40 GLY 62 A PRO 63 n 41 PRO 63 A ASN 64 n 42 ASN 64 A VAL 65 n 43 VAL 65 A THR 66 n 44 THR 66 A ASP 67 n 45 ASP 67 A PHE 68 n 46 PHE 68 A PRO 69 n 47 PRO 69 A PRO 70 n 48 PRO 70 A PHE 71 n 49 PHE 71 A HIS 72 n 50 HIS 72 A ALA 73 n 51 ALA 73 A ASN 74 n 52 ASN 74 A GLY 75 n 53 GLY 75 A THR 76 n 54 THR 76 A GLU 77 n 55 GLU 77 A LYS 78 n 56 LYS 78 A ALA 79 n 57 ALA 79 A LYS 80 n 58 LYS 80 A LEU 81 n 59 LEU 81 A VAL 82 n 60 VAL 82 A GLU 83 n 61 GLU 83 A LEU 84 n 62 LEU 84 A TYR 85 n 63 TYR 85 A ARG 86 n 64 ARG 86 A ILE 87 n 65 ILE 87 A VAL 88 n 66 VAL 88 A VAL 89 n 67 VAL 89 A TYR 90 n 68 TYR 90 A LEU 91 n 69 LEU 91 A GLY 92 n 70 GLY 92 A THR 93 n 71 THR 93 A SER 94 n 72 SER 94 A LEU 95 n 73 LEU 95 A GLY 96 n 74 GLY 96 A ASN 97 n 75 ASN 97 A ILE 98 n 76 ILE 98 A THR 99 n 77 THR 99 A ARG 100 n 78 ARG 100 A ASP 101 n 79 ASP 101 A GLN 102 n 80 GLN 102 A LYS 103 n 81 LYS 103 A ILE 104 n 82 ILE 104 A LEU 105 n 83 LEU 105 A ASN 106 n 84 ASN 106 A PRO 107 n 85 PRO 107 A SER 108 n 86 SER 108 A ALA 109 n 87 ALA 109 A LEU 110 n 88 LEU 110 A SER 111 n 89 SER 111 A LEU 112 n 90 LEU 112 A HIS 113 n 91 HIS 113 A SER 114 n 92 SER 114 A LYS 115 n 93 LYS 115 A LEU 116 n 94 LEU 116 A ASN 117 n 95 ASN 117 A ALA 118 n 96 ALA 118 A THR 119 n 97 THR 119 A ALA 120 n 98 ALA 120 A ASP 121 n 99 ASP 121 A ILE 122 n 100 ILE 122 A LEU 123 n 101 LEU 123 A ARG 124 n 102 ARG 124 A GLY 125 n 103 GLY 125 A LEU 126 n 104 LEU 126 A LEU 127 n 105 LEU 127 A SER 128 n 106 SER 128 A ASN 129 n 107 ASN 129 A VAL 130 n 108 VAL 130 A LEU 131 n 109 LEU 131 A CYS 132 n 110 CYS 132 A ARG 133 n 111 ARG 133 A LEU 134 n 112 LEU 134 A CYS 135 n 113 CYS 135 A SER 136 n 114 SER 136 A LYS 137 n 115 LYS 137 A TYR 138 n 116 TYR 138 A HIS 139 n 117 HIS 139 A VAL 140 n 118 VAL 140 A GLY 141 n 119 GLY 141 A HIS 142 n 120 HIS 142 A VAL 143 n 121 VAL 143 A ASP 144 n 122 ASP 144 A VAL 145 n 123 VAL 145 A THR 146 n 124 THR 146 A TYR 147 n 125 TYR 147 A GLY 148 n 126 GLY 148 A PRO 149 n 127 PRO 149 A ASP 150 n 128 ASP 150 A THR 151 n 129 THR 151 A SER 152 n 130 SER 152 A GLY 153 n 131 GLY 153 A LYS 154 n 132 LYS 154 A ASP 155 n 133 ASP 155 A VAL 156 n 134 VAL 156 A PHE 157 n 135 PHE 157 A GLN 158 n 136 GLN 158 A LYS 159 n 137 LYS 159 A LYS 160 n 138 LYS 160 A LYS 161 n 139 LYS 161 A LEU 162 n 140 LEU 162 A GLY 163 n 141 GLY 163 A CYS 164 n 142 CYS 164 A GLN 165 n 143 GLN 165 A LEU 166 n 144 LEU 166 A LEU 167 n 145 LEU 167 A GLY 168 n 146 GLY 168 A LYS 169 n 147 LYS 169 A TYR 170 n 148 TYR 170 A LYS 171 n 149 LYS 171 A GLN 172 n 150 GLN 172 A VAL 173 n 151 VAL 173 A ILE 174 n 152 ILE 174 A SER 175 n 153 SER 175 A VAL 176 n 154 VAL 176 A LEU 177 n 155 LEU 177 A ALA 178 n 156 ALA 178 A GLN 179 n 157 GLN 179 A ALA 180 n 158 ALA 180 A PHE 181 n 159 PHE 181 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A MET 24 13.94 1 A ILE 27 10.37 1 A ARG 28 -12.24 1 A LEU 31 -10.54 1 A GLN 33 11.17 1 A LEU 34 11.30 1 A GLY 36 -12.58 1 A TYR 46 -10.11 1 A GLN 49 -11.51 1 A ASN 56 -14.30 1 A LEU 57 11.07 1 A ASP 67 12.50 1 A PHE 71 -13.18 1 A LEU 81 12.71 1 A VAL 82 -13.62 1 A LEU 84 10.43 1 A TYR 85 -11.90 1 A ILE 87 -14.15 1 A VAL 89 -10.77 1 A LEU 91 -13.43 1 A SER 94 -12.03 1 A LEU 95 11.63 1 A ARG 100 -14.38 1 A ASP 101 -11.11 1 A ILE 104 -11.83 1 A SER 111 -14.44 1 A HIS 113 -10.84 1 A ASN 117 14.30 1 A THR 119 10.68 1 A ALA 120 -10.33 1 A ASP 121 14.73 1 A ILE 122 -10.55 1 A LEU 123 -10.06 1 A LEU 126 11.25 1 A LEU 127 -10.40 1 A LYS 137 -10.34 1 A TYR 138 12.26 1 A HIS 142 10.16 1 A ASP 144 -10.94 1 A ASP 150 -12.24 1 A ASP 155 11.14 1 A LEU 162 13.53 1 A CYS 164 -12.60 1 A TYR 170 -12.88 1 A LYS 171 -12.98 1 A SER 175 12.28 1 A VAL 176 -11.93 1 A TYR 46 0.093 SIDE CHAIN 1 A A NE2 CD2 HIS HIS 113 113 -0.071 0.011 1.373 1.302 N 1 A A NE2 CD2 HIS HIS 139 139 -0.068 0.011 1.373 1.305 N 1 A A NE2 CD2 HIS HIS 142 142 -0.072 0.011 1.373 1.301 N 1 A A CE1 CE1 HIS HIS 142 142 1.84 1_555 2_655 1 A ALA 32 -59.49 -72.38 1 A PRO 63 -49.42 103.92 1 A VAL 65 -43.03 105.02 1 A THR 66 -44.31 -91.43 1 A PRO 69 -33.66 123.57 1 A GLU 77 -35.83 -39.93 1 A ALA 109 -50.75 93.24 1 A LEU 134 -84.35 -71.26 1 A SER 136 -86.44 -156.87 1 A LYS 137 -35.67 99.87 1 A TYR 138 155.35 -39.49 1 A HIS 139 73.06 86.36 1 A VAL 145 -137.66 -36.72 1 A THR 146 61.58 86.55 1 A TYR 147 -43.27 155.00 1 A ASP 150 -105.63 53.81 1 A THR 151 -48.86 104.87 1 A SER 152 -152.74 -32.60 0.293 0.191 3.5 20.0 2728 2728 1 0 0 3.5 20.0 0 1520 0 0 1520 0.004 1.25 3.5 1EMR 2728 0.035 1 99.4 data reduction DENZO data scaling SCALEPACK model building X-PLOR refinement X-PLOR phasing X-PLOR CRYSTAL STRUCTURE OF HUMAN LEUKEMIA INHIBITORY FACTOR (LIF) CRYSTAL STRUCTURE OF HUMAN LEUKEMIA INHIBITORY FACTOR (LIF) 1 N N A ASN 25 A ASN 3 HELX_P A GLY 50 A GLY 28 1 1 26 A ASN 56 A ASN 34 HELX_P A CYS 61 A CYS 39 1 2 6 A THR 76 A THR 54 HELX_P A ASN 106 A ASN 84 1 3 31 A ALA 109 A ALA 87 HELX_P A SER 136 A SER 114 1 4 28 A ASP 155 A ASP 133 HELX_P A ALA 178 A ALA 156 1 5 24 A GLN 179 A GLN 157 HELX_P A PHE 181 A PHE 159 5 6 3 disulf 2.030 A CYS 61 A SG CYS 39 1_555 A CYS 164 A SG CYS 142 1_555 GENE REGULATION 4-helix bundle, GENE REGULATION A GLU 51 A GLU 29 1 A PRO 52 A PRO 30 2.61 LIF_HUMAN UNP 1 P15018 44 202 1EMR 23 181 P15018 A 1 1 159 1 ASP CONFLICT GLU 58 1EMR A P15018 UNP 79 36 1 ILE CONFLICT VAL 173 1EMR A P15018 UNP 194 151 1 ALA CONFLICT SER 175 1EMR A P15018 UNP 196 153 5 C 1 2 1